Clinical update on oncology treatments and trends.
This article provides a clinical update on recent trends and developments for treating non-small-cell lung, breast, and colorectal cancers and several types of non-Hodgkin's lymphoma. Included in the discussions are results from the latest clinical trials and a look ahead at further research in development. Advances in early detection and screening techniques have helped physicians to detect cancer early and increase survival rates. Monoclonal antibodies have shown promise in treating some forms of cancer and have been a successful part of treatment when coupled with chemotherapy. Such developments are helping to improve patient care and lower mortality rates.
Brooks
B Jay
BJ
Department of Hematology and Oncology, Ochsner Clinic Foundation, 9001 Summa Avenue, Baton Rouge, Louisiana 70809-3726, USA. jbrooks@ochsner.org
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004502:Education, Medical, Continuing; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008495:Medical Oncology / Q000193:education / Q000639:trends*; D009369:Neoplasms / Q000628:therapy*; D014481:United States
D000911:Antibodies, Monoclonal